冷凍消融設備市場規模、佔有率和成長分析：按產品類型、應用、技術、最終用戶和地區分類－2026年至2033年產業預測

2024 年全球冷凍消融設備市場價值為 5.217 億美元，預計到 2025 年將成長至 5.602 億美元，到 2033 年將成長至 9.9022 億美元，在預測期（2026-2033 年）內複合年成長率為 7.38%。

全球冷凍消融設備市場的主要驅動力是慢性疾病盛行率的上升和對微創治療方法需求的成長。該領域包括利用低溫去除病變組織的設備，應用於循環系統、腫瘤學和疼痛管理等領域，透過減少住院時間和併發症，顯著改善患者預後。影像和溫度控制技術的創新正在推動冷凍球囊療法和經皮系統的應用，以提高手術安全性。越來越多的臨床證據支持冷凍消融的有效性，這促使臨床醫生和保險公司加強對該技術的接受度，並推動醫院增加對門診設施的投資。此外，腫瘤學領域的成功案例，尤其是在腎臟和肺部腫瘤的治療方面，與免疫療法產生了協同效應，開闢了新的市場機遇，並為創新可攜式系統的發展鋪平了道路。

全球冷凍消融設備市場的成長要素

全球冷凍消融設備市場的成長主要得益於臨床醫生對微創冷凍消融技術的日益青睞，因為此類技術具有更高的安全性和更短的預期恢復時間。這一趨勢促使包括醫院和門診中心在內的醫療機構將這些先進技術納入其治療方案。更高的手術精度、更小的切口和更徹底的目標組織破壞等優勢，使得冷凍消融技術在臨床上的應用不斷擴展，涵蓋了各個醫學專科。隨著患者舒適度和縮短住院時間在醫療機構中變得日益重要，冷凍消融設備被視為醫療基礎設施的重要補充，從而促使醫療機構加大對培訓和採購的投入，以提升服務品質並適應現代醫療標準。

全球冷凍消融設備市場的限制因素

全球冷凍消融設備市場面臨嚴峻挑戰，主要原因是冷凍消融系統、探針及必要的手術配件初始成本高。這可能會阻礙醫院採購，並限制其應用，尤其是在資源有限的環境中。此外，不同支付方的報銷政策各異，保險覆蓋範圍指南不明確，也為考慮拓展服務的醫療機構帶來了財務上的不確定性。因此，許多管理者可能會選擇投資報酬率較為確定的傳統治療方法。這些因素會導致採購週期延長，並促使醫療機構採取更保守的推廣策略，從而限制市場成長，直到經濟效益改善、保險覆蓋範圍更加清晰為止。

全球冷凍消融設備市場趨勢

全球冷凍消融設備市場正呈現出顯著的臨床適應症拓展趨勢，醫療專業人員擴大將這項技術應用於更廣泛的腫瘤類型和心律不整病變。這項轉變的驅動力在於對器官保留、微創治療方法的需求，以期改善患者預後。製造商正積極探索更廣泛的適應症，並進行研究者主導的臨床試驗，以驗證冷凍消融在新的解剖區域的安全性和有效性。隨著患者對更短恢復時間和更少併發症的需求日益成長，與學術機構的合作研究以及針對複雜解剖結構量身定做的設備設計，正進一步加速臨床應用，並確保市場穩健且永續的成長。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球冷凍消融設備市場規模：依產品類型分類

• 冷凍消融系統
  • 主機台式系統
  • 可攜式冷凍消融系統
• 低溫探針
  • 一次冷凍探針
  • 可重複使用的低溫探針
• 配件和耗材
  • 氣瓶
  • 針頭和導管
  • 用於監測和指導的配件
  • 其他

全球冷凍消融設備市場規模：按應用領域分類

• 腫瘤學
  • 肺癌
  • 乳癌
  • 肝癌
  • 腎癌
  • 攝護腺癌
  • 骨骼和軟組織腫瘤
  • 其他
• 循環系統
  • 心房顫動
  • 心律不整
• 皮膚科
• 婦科
• 疼痛管理
• 泌尿系統
• 其他

全球冷凍消融設備市場規模：依技術分類

• 液態氮冷凍消融術
• 氬氣冷凍消融
• 使用氧化亞氮進行冷凍消融

全球冷凍消融設備市場規模：依最終用戶分類

• 醫院
• 專科診所
• 門診手術中心
• 癌症治療中心

全球冷凍消融設備市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic
• Boston Scientific Corporation
• Johnson & Johnson MedTech
• Varian Medical Systems
• IceCure Medical Ltd.
• AtriCure, Inc.
• CooperSurgical, Inc.
• Metrum Cryoflex
• Galil Medical
• C2i Genomics
• Erbe Elektromedizin GmbH
• Celsion Corporation
• Apyx Medical Corporation
• Cardinal Health
• Stryker Corporation
• AngioDynamics, Inc.
• BTG International Ltd.
• SeedNet Gold Cryotherapy
• Zimmer Biomet
• Cynosure LLC

結論與建議

Global Cryoablation Devices Market size was valued at USD 521.7 Million in 2024 and is poised to grow from USD 560.2 Million in 2025 to USD 990.22 Million by 2033, growing at a CAGR of 7.38% during the forecast period (2026-2033).

The global cryoablation devices market is primarily driven by the increasing prevalence of chronic diseases and a growing demand for minimally invasive treatment options. This sector encompasses devices that utilize extreme cold to eliminate pathological tissue in fields such as cardiology, oncology, and pain management, significantly improving patient outcomes by reducing hospital stays and complications. Innovations in imaging and temperature regulation have advanced the use of cryoballoon treatments and percutaneous systems, enhancing procedural safety. The burgeoning clinical evidence supporting cryoablation's effectiveness boosts clinician adoption and payer backing, leading to increased hospital investments in outpatient facilities. Additionally, successful applications in oncology, particularly in renal and lung tumor therapies, foster synergy with immunotherapy, paving the way for emerging market opportunities and innovative portable systems.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cryoablation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cryoablation Devices Market Segments Analysis

Global cryoablation devices market is segmented by product type, application, technology, end user and region. Based on product type, the market is segmented into Cryoablation Systems, Cryoprobes and Accessories & Consumables. Based on application, the market is segmented into Oncology, Cardiology, Dermatology, Gynecology, Pain Management, Urology and Others. Based on technology, the market is segmented into Liquid Nitrogen-Based Cryoablation, Argon Gas-Based Cryoablation and Nitrous Oxide-Based Cryoablation. Based on end user, the market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Cancer Treatment Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cryoablation Devices Market

The growth of the Global Cryoablation Devices market is significantly influenced by the rising preference among clinicians for minimally invasive cryoablation techniques, which are recognized for their excellent safety profiles and the potential for quicker recovery times. This trend encourages healthcare facilities, including hospitals and outpatient centers, to integrate these advanced technologies into their treatment protocols. With benefits such as enhanced procedural accuracy, smaller incisions, and targeted tissue destruction, the clinical adoption of cryoablation continues to widen across various medical specialties. As healthcare increasingly prioritizes patient comfort and reduced hospital stays, cryoablation devices are viewed as valuable additions, leading to increased investments in training and procurement to enhance service offerings and adapt to modern care standards.

Restraints in the Global Cryoablation Devices Market

The Global Cryoablation Devices market faces significant challenges due to high initial costs related to cryoablation systems, probes, and necessary procedural accessories, which can hinder hospital purchases and limit adoption, especially in resource-limited environments. Additionally, varying reimbursement policies and unclear coverage guidelines from different payers contribute to financial uncertainty for healthcare providers considering service expansion. As a result, many administrators may opt for conventional treatment methods that promise more reliable returns on investment. These factors can lead to prolonged procurement timelines and conservative adoption strategies, ultimately restricting market growth until there is greater economic viability and clearer coverage options.

Market Trends of the Global Cryoablation Devices Market

The Global Cryoablation Devices market is witnessing a significant trend towards expanding clinical indications, as medical professionals increasingly adopt these technologies for diverse tumor types and arrhythmia substrates. This shift is fueled by a desire for organ-preserving, minimally invasive treatment alternatives that enhance patient outcomes. Manufacturers are actively pursuing label expansions and conducting investigator-led studies to establish the safety and efficacy of cryoablation in novel anatomical areas. As patient demand for shorter recovery times and minimal collateral damage rises, collaborative initiatives with academic institutions and tailored device designs for complex anatomies further promote widespread clinical adoption, ensuring robust and sustainable market growth.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Cryoablation Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Cryoablation Systems
  • Console-Based Systems
  • Portable Cryoablation Systems
• Cryoprobes
  • Single-Use Cryoprobes
  • Reusable Cryoprobes
• Accessories & Consumables
  • Gas Cylinders
  • Needles & Catheters
  • Monitoring & Guidance Accessories
  • Others

Global Cryoablation Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oncology
  • Lung Cancer
  • Breast Cancer
  • Liver Cancer
  • Kidney Cancer
  • Prostate Cancer
  • Bone & Soft Tissue Tumors
  • Others
• Cardiology
  • Atrial Fibrillation
  • Arrhythmias
• Dermatology
• Gynecology
• Pain Management
• Urology
• Others

Global Cryoablation Devices Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Liquid Nitrogen-Based Cryoablation
• Argon Gas-Based Cryoablation
• Nitrous Oxide-Based Cryoablation

Global Cryoablation Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Cancer Treatment Centers

Global Cryoablation Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Application, Technology, End User)
  • US
  • Canada
• Europe (Product Type, Application, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Technology, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson MedTech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IceCure Medical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AtriCure, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metrum Cryoflex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galil Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C2i Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Erbe Elektromedizin GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celsion Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apyx Medical Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BTG International Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SeedNet Gold Cryotherapy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cynosure LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations